Skip to main content

Table 3 Differences in co-morbidity amongst normal weight (BMI 18.5 to < 25.0 kg/m2) and obese (BMI > 35 kg/m2) participants that tested positive for Covid-19

From: Increasing adiposity and the presence of cardiometabolic morbidity is associated with increased Covid-19-related mortality: results from the UK Biobank

 

Normal weight (BMI18- < 25 kg/m2)

Obese (BMI > 35 kg/m2)

Odds ratio (95% CI)

P

Number (n)

389

204

–

–

Age (mean years ± SD)

67 ± 9

68 ± 9

–

0.20

Hypertension (n)

84

119

5.08 (3.53–7.30)

< 0.0001

Dyslipidaemia (n)

42

64

3.78 (2.44–5.84)

< 0.0001

Atrial fibrillation (n)

24

29

2.52 (1.46–4.48)

0.0021

Ventricular arrhythmia (n)

5

1

0.38 (0.032–2.76)

0.67

Diabetes (n)

15

67

12.19 (6.71–22.19)

< 0.0001

Stroke (n)

6

5

1.60 (0.55–5.47)

0.52

Angina (n)

20

38

4.22 (2.40–7.38)

< 0.0001

  1. Amongst those testing positive for Covid-19, participants with BMI > 35 kg/m2 (obese II) have greater odds ratios for hypertension, dyslipidaemia, atrial fibrillation, diabetes and angina than individuals with normal weight (BMI 18.5 to < 25.0 kg/m2). There were no differences between groups for stroke and ventricular arrhythmia. T test was used to test for differences in age between groups, and Fisher’s exact test for categorical variables
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us